Spectral Medical Inc T.EDT

Alternate Symbol(s): EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.

TSX:EDT - Post by User

Spectral Medical Inc > Under promise and

<< Previous

Bullboard Posts

Next >>

Comment by BayStreetWildon Dec 08, 2021 9:10pm

81 Views

Post# 34212916

RE:RE:RE:RE:RE:RE:RE:RE:Under promise and

you can throw more money to fix a delay but you can't throw more money to fix stupid or a lie.

BayStreetWild wrote:

Every time a promise was made and the timeline was not met * such as Tigris 60% enrolment and dialco trial start* or the opposite happened *such as with the financing* the price dipped. Over and over. Credibility was lost as serious people don't stand for that carp. Hopefully they've learned from those mistakes. If they were forthcoming with investors right away they would have taken way smaller of a price beating as investors would have stood behind them.

Imagine 3 people living in a house, two parents and a kid. You come home and there is crayon all over the walls. You ask the kid who did it... the kid replies... not me! That's how obvious the bull5hit was all last year. To everyone except IR and management. In effect making them look inexperienced and moronic. Not someone you want to leave your money with. If they came out in august/sept and discussed the delay we wouldn't be here today. Delays happen, people understand.

hopefully they learned something from their mistakes.

Domino55 wrote:

The share price has managed to drop to near worthless with the Baxter relationship in hand. What is to say it won't be the same with a DaVita deal? Since the inception of the company what milestone has led to a sustained share price increase? None...It is 23 cents bud.

BTW You forgot to comment on the 2% NPV valuation or if you prefer all time lows.